In today’s Pharmaceutical Executive Daily, learn how Abbott is acquiring Exact Sciences in a major diagnostics deal, Novartis ...

Tesaro confirmed its litigation against AnaptysBio in the Delaware Chancery Court in a press release on its website, ...

Pharmaceutical collaborations expand as Flagship Pioneering expands its partnership with GSK, signing agreements with ...

Jay Bregman, co-founder of Andel, the cost and operational complexity of covering GLP-1 medications.

In the first part of our conversation with Ryan Conrad, visiting fellow at the Center on Health Policy at the Brookings Institution, he provides a broad overview of the possible positive and negative ...